DB12607InvestigationalProtein Based Therapies
Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants).
- Mechanism
- Curator reviewed
Pharmacologically active on Hemagglutinin
- Code names
- CR6261
Resolves to
Compound
Targets
What you can answer from here — as of July 07, 2026
Which drugs share a target with Diridavumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account